Skip to main content
Equibles
NRIX $26.38 -1.86%
NRIX logo
NRIX · Nurix Therapeutics, Inc.
Track NRIX — free

Use NRIX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about NRIX

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$26.38 -0.50 (-1.86%)
Russell 2000 member Rebalance outlook locked
Market Cap
$2.79B
Shares
103.78M
All earnings calls

Earnings call · FY2024 Q2

Nurix Therapeutics, Inc. (NRIX) Q2 2024 Earnings Call

Concluded Jul 11, 2024
Jul 11, 2024 0 turns
Period
FY2024 Q2
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue $12.09M -60.6% YoY
Diluted EPS -$0.71
Net income -$44.55M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Jul 11, 2024 10-Q report Filed Jul 11, 2024

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Collaboration Revenue$12.09M +13.3% YoY
License Revenue$0 -100% YoY
Full-screen source Call document

Report a Problem

Category
Description
Email (optional, for follow-up)